Glyphic Biotechnologies

After years investing at the intersection of AI and biology, I’ve never been more convinced that we’re entering a new era: one where biology becomes a digital system. Excited to share my latest article: “The Digital Bio Revolution: Transforming Healthcare” on Business Insider. From AI-designed drugs to immune system twins and mRNA programming, the speed of innovation is accelerating. At FoundersX Ventures, we’re proud to back founders building this future: 1910, Kernal Biologics, Glyphic Biotechnologies, Omniscope, and Zafrens. This isn’t just incremental progress, it’s a reimagining of biology itself, and the foundation of a more efficient, equitable, and sustainable healthcare system. 🔗 Read the full article here: https://lnkd.in/eZ9mfM3a #DigitalBio #AI #DeepTech #Biotech #DrugDiscovery #HealthcareRevolution #Healthcare Helen H. Liang, PhD Sizi Chen Tristan Staschik Murray Newlands Tor Parawell Tom Kosnik Vijay Vaswani Nitesh Shroff Jen Asher, Ph.D. Josh Yang Swamy Vijayan

🧪✨ Glyphic is hiring a (Senior) Director of Chemistry. In this role, you'll lead an intellectually diverse team of chemists (using polymer, surface, bioconjugation, peptide, and nucleic acid chemistries) to bring proteome sequencing to life. 🧬 Design novel reagents and chemistries ⚡ Collaborate with assay and automation leaders 💡 Be a major stakeholder in a category-defining technology Qualified candidates for this role are technically exceptional, have contributed to a commercially successful product, and are extraordinarily proactive in identifying and resolving technical bottlenecks. https://lnkd.in/gkKhTqFD

🚨 5 days left! This is your final call to apply for the Nucleate Activator 2025–2026 and join a community where bold ideas in biotech turn into real ventures. Whether you’re building new therapeutics, diagnostics, or biomanufacturing technologies, or reimagining sustainability through synthetic biology, the Activator is your launchpad. We’re looking for: > Founders — scientists with early-stage ideas ready to grow. > Contributors — business, clinical, or technical minds eager to help build what’s next. What makes the Activator different? ✅ Free and equity-free—we take nothing. ✅ Mentorship from top-tier biotech founders, VCs, and pharma partners. ✅ Global network of 40+ chapters, 400+ institutions, and thousands of innovators. ✅ High-visibility pitch opportunities at our Global Summit, Demo Days, and partnered challenges. ✅ Expertise in IP, regulatory strategy, clinical development, and BD—at zero cost. 🚀 Applications close on October 20th! 🔗 Apply here: https://lnkd.in/g_6ur6iF 🌐 Learn more: https://lnkd.in/gP85JuUt Over the past 7 years, Nucleate has supported 690+ venture teams, with our alumni raising over 550M to develop cutting-edge technologies like protein sequencing (Glyphic Biotechnologies), drug design (Manifold Bio), microbe-based therapeutics (Concerto Biosciences), and biomanufacturing (Foray Biosciences https://foraybio.com/) and many more. ⏳ Applications are reviewed on a rolling basis. #Biotech #Entrepreneurship #AcademicInnovation #LifeSciences #NucleateActivator #FutureFounders #SynBio #TechBio

✨ A N O T H E R O N E ✨ Glyphic Biotechnologies is seeking an SRA/Scientist to join our nascent Platform Development team. If you... 🧑🔬 have >2 years of experience in assay or process dev 🔬 care about solving the most important problem in life science 🤩 want an encouraging & technically skilled mgr (Nick Groves) 🏃 know you are built for a fast-paced environment 🧠 are obsessed with the details ...we want to hear from you 🫵 -- https://lnkd.in/gMD9tzen

Help make this dream a reality with Protein Sequencing by Expansion — what we’re calling ProSE —at Glyphic Biotechnologies Send all rockstars that might fit the mold our way!

I’m excited to present what has been described by one candidate as an “actually good Data Science JD” 😂 Want to make your mark on a technology that will enable new categories of biological insight? Come work with us at Glyphic Biotechnologies as we usher in the Era of NGPS ✨ — https://lnkd.in/giBngs6i

✨ The year is 2050 ✨ 💊 // Personalized immunotherapies have all but eliminated cancer and obviated chemotherapy. 🩸 // Predictive biomarkers of Alzheimer's can be detected via blood at the earliest stage of disease, and new treatment modalities have emerged for AD, MCI, LBD and other progressive neurological conditions. 💡 // We understand the precise physiological basis of sleep 😴, memory 📚, consciousness 💭, and aging 👵. 🫵 // There's probably a Wikipedia article about you. ... all of that because you joined Glyphic Biotechnologies as Vice President of Platform Development and set to task developing the world's first truly de novo single molecule proteome sequencing platform. Apply below and contribute to the ambitious vision of a world made better by NGPS. https://lnkd.in/gy4d5P5u

I'm recruiting for a Senior Scientist to lead peptide chemistry efforts at Glyphic Biotechnologies. This is a great opportunity to join a close-knit team that is tackling one of the biggest gaps in biology - de novo protein sequencing. If you're an expert in peptide conjugation, please check out the following post. https://lnkd.in/gx3Q8Qzq #peptidechemistry #bioconjugation #aminoacidchemistry #biotechjobs #bayareajobs

Glyphic Biotechnologies is ushering in the protein revolution with single-molecule proteome sequencing. Check out open technical positions (VP, Research and Senior Scientist, Biopolymer Chemistry) with Josh Yang and the amazing Glyphic team: https://lnkd.in/exT6xXug